Cargando…
Carboxypeptidase N1 is anticipated to be a synergy metrics for chemotherapy effectiveness and prognostic significance in invasive breast cancer
BACKGROUND: The incidence and mortality of invasive breast cancer (IBC) are increasing annually. Hence, it is urgently needed to determine reliable biomarkers for not only monitoring curative effects, but evaluating prognosis. In present study, we aim to determine the potential role of Carboxypeptid...
Autores principales: | Cui, Ranliang, Wang, Chaomin, Li, Tiantian, Hua, Jialei, Zhao, Ting, Ren, Li, Wang, Yichao, Li, Yueguo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555242/ https://www.ncbi.nlm.nih.gov/pubmed/34711246 http://dx.doi.org/10.1186/s12935-021-02256-5 |
Ejemplares similares
-
Clinical value of ROMA index in diagnosis of ovarian cancer: meta-analysis
por: Cui, Ranliang, et al.
Publicado: (2019) -
Prognostic significance of carboxypeptidase Q and its methylation in glioblastoma
por: Liu, Qiaodan, et al.
Publicado: (2023) -
High Expression of RAI14 in Triple-Negative Breast Cancer Participates in Immune Recruitment and Implies Poor Prognosis Through Bioinformatics Analyses
por: Cui, Ranliang, et al.
Publicado: (2022) -
Prognostic significance of CXCR7 in cancer patients: a meta-analysis
por: Fan, Huiqian, et al.
Publicado: (2018) -
CARBOXYPEPTIDASE : III. THE ESTIMATION OF CARBOXYPEPTIDASE AND PRO-CARBOXYPEPTIDASE
por: Anson, M. L.
Publicado: (1937)